Compared to GHRP-2 (D-Ala-D--Nal-Ala-Trp-D-Phe-Lys-NH2, 817 Da): Ipamorelin induces similar GH release but without detectable cortisol, ACTH or prolactin elevation at effective doses, while GHRP-2 modestly elevates these hormones at high doses
Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue, first described by Raun and colleagues in 1998 as the first selective growth hormone secretagogue. It remains one of the most extensively characterised compounds of its class in the published research literature
doi: 10.1056/NEJMoa2107519 50 FinanBYangBOttawayNSmileyDLMaTClemmensenCet al
September 5th, 2025: Research Suggests GLP-1 Medications May Raise Kidney Cancer Risk Amid Growing Litigation A new study published in JAMA Oncology suggests that GLP-1 receptor agonists such as Ozempic and Mounjaro could increase the risk of kidney cancer, despite appearing to lower the risk of certain other cancers
Providers generally look for a BMI of 30+, or 27+ with a weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or sleep apnea
M.KhanJ